Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
Active filters
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Melatonin 3mg/5ml oral suspension
0401010ADAACBCB
|
Melatonin | Melatonin | Central Nervous System | 113 |
|
Melatonin 4mg/5ml oral suspension
0401010ADAADCDC
|
Melatonin | Melatonin | Central Nervous System | 108 |
|
Melatonin 2.5mg capsules
0401010ADAAAHAH
|
Melatonin | Melatonin | Central Nervous System | 106 |
|
Melatonin 2mg modified-release capsules
0401010ADAACHCH
|
Melatonin | Melatonin | Central Nervous System | 59 |
|
Melatonin 3mg modified-release tablets
0401010ADAAAQAQ
|
Melatonin | Melatonin | Central Nervous System | 8 |
|
Melatonin 5mg/5ml oral solution (old)
0401010ADAADDDD
|
Melatonin | Melatonin | Central Nervous System | 5 |
|
Melatonin 2.5mg tablets
0401010ADAACRCR
|
Melatonin | Melatonin | Central Nervous System | 3 |
|
Melatonin 4mg capsules
0401010ADAAAUAU
|
Melatonin | Melatonin | Central Nervous System | 2 |
|
Melatonin 8mg capsules
0401010ADAABJBJ
|
Melatonin | Melatonin | Central Nervous System | 2 |
|
Melatonin 10mg tablets
0401010ADAACNCN
|
Melatonin | Melatonin | Central Nervous System | 1 |
|
Melatonin 1mg/5ml oral liquid
0401010ADAABTBT
|
Melatonin | Melatonin | Central Nervous System | 1 |
|
Melatonin 1mg/ml oral drops
0401010ADAACTCT
|
Melatonin | Melatonin | Central Nervous System | 1 |
|
Melatonin 6mg capsules
0401010ADAABVBV
|
Melatonin | Melatonin | Central Nervous System | 1 |
|
Melatonin 6mg modified-release capsules
0401010ADAACXCX
|
Melatonin | Melatonin | Central Nervous System | 1 |
|
Melatonin 6mg tablets
0401010ADAACQCQ
|
Melatonin | Melatonin | Central Nervous System | 1 |
|
Melatonin 6mg/5ml oral liquid
0401010ADAABWBW
|
Melatonin | Melatonin | Central Nervous System | 1 |
|
Melatonin 15mg/5ml oral suspension
0401010ADAACKCK
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 20mg capsules
0401010ADAABMBM
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 3mg lozenges sugar free
0401010ADAABIBI
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 3mg orodispersible tablets
0401010ADAACCCC
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 4mg/5ml oral solution
0401010ADAABGBG
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 500microgram capsules
0401010ADAAACAC
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 500microgram tablets
0401010ADAAASAS
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 7.5mg capsules
0401010ADAACICI
|
Melatonin | Melatonin | Central Nervous System | No data available |
|
Melatonin 7mg capsules
0401010ADAACMCM
|
Melatonin | Melatonin | Central Nervous System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.